PAIN IS COMPLEX. When we talk about pain, we can’t help but draw from our own experience. Think about a time you might have been in pain. For me, it’s a recurrent low back pain which emerges every so often to remind me that being tall isn’t always a great thing. For you, it might be something different.Whilst you may not be able to summon up the actual sensation again, I’m sure you can recall the fear and anxiety, the worry about the implications to your personal and social life. Pain might fade over time, but the emotional and social impact often remains.
As a result, when you try and treat pain, you neglect the whole person at your peril. While drugs can ease the physical suffering, the effect of that pain on the person’s life, relationships, and their standing in the world may go neglected.
This complex interrelationship was strikingly laid bare at ‘Ugly Lies the Bone’, which I saw at the National Theatre last week.
This is the second revival of the Lindsey Ferrentino‘s play, set in the heart of Florida’s Space Coast in 2011 at the time of NASA’s last shuttle flight. It focuses on the return of Jess, a veteran of the conflict in Afghansitan, horribly injured in an IED explosion. As part of her treatment she takes part in revolutionary new Virtual Reality therapy that helps her to escape her pain. As the play progresses, just what form that pain takes becomes clearer – the physical pain of her scars, the emotional and social pain of her return to her home and the effect this has on her friends and family, and how Post Traumatic Stress Disorder never lets her fully escape
One of the characters in the play is simply listed as ‘Voice’ – the verbal presence of the therapist during Jess’ sessions in VR. Being a therapist myself I was particularly affected by her role, and it served to reflect the rather shallow focus that I’ve been guilty of in the past. Concentrating on the numerical rating of the pain, and the short-term goals of the treatment, the disembodied clinician seems to drift away from the other components of her patient’s pain, leaving her stranded once the game is complete.
VIRTUAL REALITY HOLDS REAL PROMISE FOR MANAGING PAIN. From distraction and manipulation of the senses, to the respite from reality, and the freedom from physical limitation, we’re seeing examples every day of how this new technology can help people.
Two days after the trip to the National Theatre, I was able to explore this in much more detail in a meeting held at Digital Health: London. There I met with Howard Rose, CEO of Deepstream VR, and leader in the field for over 20 years. In attendance we also had Nick Peres, creator of PatientVR.co.uk and champion of immersive VR. Richard Dolan, Innovation lead at NHS Dorset CCG.
We spent two hours experiencing COOL! and GLOW!, both Firsthand VR products used for the management of acute and chronic pain, and anxiety. Cool! was of particular relevance, as it is the direct ‘descendent’ of SnowWorld – the VR experience that played a part in inspiring the story of ‘Ugly Lies the Bone’. As with all VR, it’s a little difficult to convey the experience without it sounding daft – after all, I was throwing iridescent trout and glowing orbs at otters playing on the riverbank – but it did work to reduce my back pain.
GLOW! was particularly beguiling. In this I found myself sitting next to a stone totem with my heart rate illuminated on the rock face. A Leap Motion controller, attached to the front of the headset, meant I could see glowing outlines of my hands, which would summon and dispel fireflies as I opened and closed my hands. The stars above, the cicadas, and the babbling water, all conveyed through stereoscopic images and binaural sound had a remarkable effect on my pulse, leaving me calm and comfortable for hours afterwards.
We then moved on the PSIOUS VR, which was demo’d by Richard Dolan. Psious is a Gear VR/Laptop based mental health application used to help treat mental health problems, particularly phobias and anxiety. Linked to a stress measuring wearable, the therapist is able to tailor a variety of scenarios to expose the patient in a safe and graduated way to their fears. Accordingly, I sweated my way up a construction lift bolted to the outside of a skyscraper, whilst Nick was taken through a personal fear – preparing for take-off in a commercial jet. Whilst the graphics were more basic than those of COOL! and GLOW!, it was astonishing how they nevertheless generated that familiar discomfort. The level at which VR can deliver benefit – at which point the immersion is ‘good enough’, is a question for researchers and those evaluating VR in healthcare.
Richard works as Innovation Lead at Dorset Clinical Commissioning Group, and it was great to see such a passion for innovation, especially within the NHS. I meet many CCG staff in the Digital Health sphere, and it’s encouraging to find everyone reaching out to each other and beginning to develop networks to share learning and opportunities. Similarly, Nick Peres at Torbay NHS Trust is doing amazing work with 360 video in highlighting the important of human touch in healthcare – patientvr.co.uk. You can find out more about his story on my podcast, CURISTICA.
WE’RE ALL AFFECTED BY PAIN IN DIFFERENT WAYS. Some, like Jess, suffer the full spectrum of misery. Others have a thankfully more fleeting acquaintance. For each person, Virtual Reality has a potential role to play. What was made clear in the play, and at the meeting, was how this role could be across every facet of pain – the physical, emotional, cognitive and social. Given that VR is also not the sole preserve of the clinician, it suddenly becomes a much more interesting proposition. Unlike prescribed drugs, the tools for relief and recovery are now in the hands of the patient.
We need to work carefully to understand what evidence there is for benefit in acute and chronic pain. Are there potential risks or harms? Will VR work only while the user is immersed, or does it persist afterwards? We already have published evidence supporting VR analgesia, but precious little about how it can be scaled, and provided equitably.
For now, I go back to my day job a little wiser and more optimistic than I was before. As a Doctor,I need to step back and always consider the wider implications that pain has on an patient’s life. Maybe I can bring new hope to some of my more troubled patients, for those that have found conventional medicine lacking or limited by side effects. Maybe next time my back seizes up, I’ll reach for the headset before the tablets.
Links & Declarations
I’d like to thank Nick, Rebekah, and Yinka at Digital Health: London for their kind assistance in providing a room for the meeting. All of the participants are colleagues I’ve met through meetings and on my voyage of Digital Health discovery through Social Media. I have no financial interest in any of the companies mentioned, although I am an NHS GP and CCG governing body member (Eastbourne Hailsham and Seaford).
All costs for these events, including travel and tickets, were paid for personally. My back pain is sadly provided for free.
Digital technology is radically transforming how we deliver healthcare. Join me, Dr Keith Grimes – Geek, Gamer, and General Practitioner, as I share the stories of the people I’ve met as I explore this incredible and vibrant new discipline in Medicine.
This first episode features Nick Peres, founder of PatientVR.co.uk. Nick is using 360 video and low-cost headsets to deliver radically new perspectives for healthcare workers learning their trade, by putting them in the shoes of their patients.
If knowledge is power, then from 7th century BC to the 4th century AD, the most powerful women of the classical world were undoubtedly the Oracles of Delphi.
Supplicants would travel far to seek the Pythia’s wisdom, delivered in ecstatic frenzy after inhaling the spirit of Apollo. Such was the cryptic nature of their utterances that prophets would be employed to help travelers make sense of their revelations.
Important decisions in matters of war, trade, marriage, and business, all made with reference to the divine knowledge imparted by the Oracle.
In matters of medicine, doctors have been the gateway to knowledge. With that, doctors have significant power in the war against disease.
On the afternoon of 22nd February I went to Digital Health.London’s ‘Collaborate’ event. It was a celebration of the programme’s first year’s work, an award ceremony, and innovation event all rolled into one. They were kind enough to let me speak about Virtual Reality in patient care as well.
There was a fantastic, diverse audience in attendance too, from the cutting-edge 360 live-streaming surgeon Shafi Ahmed, to my colleague Sunil Bhudia (with whom I’m working on the PREVENT-ICU-Delirium project), and the inspirational Molly Watt, who took part in a panel discussion about accessibility and digital participation. It’s also brilliant to meet people I know from twitter face-to-face, like Victoria Betton, who led a session on hacking STPs), and Dr Robert Lloyd, who skillfully MC’d the proceedings
So why the Delphi reference? Of all the talks, the most fascinating for me was the panel discussion on Artificial Intelligence.
Patients should use Artificial Intelligence to reduce the amount of time they need to spend with healthcare professionals
The panel comprised of three heavyweights in the Digital Health field:
Dr Ameet Bakhai Consultant Cardiologist Royal Free Foundation NHS Trust
Professor Nicholas Peters – Professor of Cardiology & Electrophysiologist at Imperial College London
Entertainingly and insightfully chaired by Dr Jordan Schlain , a fellow US based GP and Founder of HealthLoop, the debate fell nicely into those for, against, and balanced on the fence.
Ali Parsa began with a blistering defense of clinical AI, delivering an impassioned argument for how it can meet the yawning gap in healthcare provision around the globe. His team at Babylon have seen an 80% reduction in conversion of clinical inquiries to video consultations since the introduction of their triage AI. As far as he is concerned, there is a moral duty to implement AI to meet the care divide, and augment the diagnostic capabilities of clinicians.
It’s difficult to come back against that kind of rhetoric, although I would posit that Babylon’s UK business deals with a small proportion of range of presentations seen in General Practice, and from a significantly healthier and wealthier cohort. It might be difficult to extrapolate the 80% reduction in demand. With an ongoing trial front-ending GP in North London though, I guess time will tell.
The progress in developing world is also laudable, but I wonder whether it can ever cover the totality of care needs? Perhaps 10% of something better than 100% of nothing.
The issue of AI treating humans well and not turning them into batteries comes up time and again, and from my own point of view I swing between optimism and existential dread. It’s not unique to patient care, but does have an interesting twist in that should AI be successful in helping the patient, it may harm the doctor.
As for empathy, this is stronger ground. I certainly believe that humans need contact with other humans, particularly when it comes to the ritual of the consultation. Who’s to say that empathy is a uniquely human property though? Any pet owner will attest to the ability of their loved companions to deliver comfort without words. In time, empathy may well be better delivered by machine, especially to those raised in the post-millennial world – Homo Digitalis .
Professor Peters was left to adopt the middle ground, adding nuance to the preceding statements. I was particularly taken by his observation that the addiction that doctors have to treating patients, felt as a need deeper than simply a method of paying the bills, coloured their opinion. AI and the fear of being replaced and made worthless affect us all.
The framing of the debate made this last point ironic – there were no patients on the panel discussion the proposition. I raised this point, which was countered with an anecdote about Henry Ford who was quoted as saying that if he’d given the public what they wanted, he’d have made a faster horse. Professor Peters also referenced Molly Watts’ support of Apple’s commitment to user interface excellence & accessibility, which comes despite their famous lack of user input. All good points, but I’d still want to hear a patient make them.
The concept of Artificial Intelligence has been around since the 1950s, and we’ve seen this level of enthusiasm before. We’ve also had our hopes dashed before. I believe we’re entering a time when some of that promise will be realised, especially in narrow specialist areas. For this reason, I see the generalist physician outliving the specialist when it comes to head-to-head performance against AI in terms of patient care. Before my GP colleagues get too comfortable, even that advantage will pass in time, leaving the nurses as the most valuable humans in the healthcare system.
It may be that we will co-exist as providers of healthcare, but surely there will come a time when AI will be superior to human in a number of areas. When this happens, if we truly respect tradition of medicine, and believe we must first do no harm, maybe doctors should stop diagnosing patients?
And with that, is the best that doctors can wish for is to become gatekeepers of the knowledge – prophets at Delphi helping the patient understand the superhuman wisdom of the AI oracle? Or will this knowledge by available to the patients directly, leaving doctors shorn of their power?
It’s no surprise that our excitement is tinged with fear.
“Whilst research into the use of VR for healthcare dates back to the 1980s, recent advances in high quality/low cost equipment have seen an explosion of interest in the practical applications in health and social care.
By sharing his experience of using VR with patients, Dr Keith Grimes will explore the history of Medical VR, share current projects, and discuss the future of the field, where the consulting room might very well be a co-created space in Minecraft.”
This is slide & audio recording of the presentation I made at Develop VR in London on Thursday 1st December, 2016.
Please make contact via www.facebook.com/groups/VRDocs
Imagine that this care was provided based on clinical need, not your ability to pay.
Imagine if we arranged it so that it was provided free at the point of delivery as well.
If we didn’t have this already, you’d laugh me out of the room
The National Health Service is the very definition of a disruptive innovation.
The NHS was born into a country emerging from the rubble of a World War, where food and basic amenities were rationed. The concept behind it was so radical that many doctors fought to prevent it coming into existence. Yet, created it was, and nearly 70 years later it continues to make good on those three founding principles.
You’d think that a health service so radically innovative would be receptive to innovation, but in the twenty years I’ve been working in the NHS I’ve come to see that it is anything but. The pressure not to mess with the formula is high.
No-one wants to be the person that broke the NHS.
Bureaucracy and the conservatism of the medical profession preserve the status quo. Any innovation has to be controlled and managed: only proven innovations are to be permitted.
That’s not really how innovation works though.
I’m a ‘lifer’ – the NHS has been caring for me since before I was born, and I’ve been raised, trained, work, and (with any luck) I’ll retire, be cared for, and eventually die in a world where the NHS continues.
I want to play my part to ensure that this be the case, but I’ve never felt that there was a recognized career path for me as a technologically minded doctor. I’ve been forced therefore, to try and bring tech in to my work “on the side”, often on my own, in my own time, and experiencing considerable resistance.
I affectionately refer to some of my attempts as: “The Good, the Bad, and the Ugly”.
The “Good” are innovations that work well within the boundaries of the NHS. I collaborated on an ingenious project called ‘MyLittleOne’ recently which, using a specially developed camera and iPad system, allows mothers to see their babies when they’re receiving care in the Neonatal ICU.
The “Bad” are those that don’t work, or don’t scale. They also tend to be the ones that are solution led, rather than problem driven. In my case, it was Google Glass that seduced me. I may have looked foolish as an early adopter, but I learned valuable lessons that have led to my CCG being on the brink of using this technology to provide remote care in local nursing homes.
The “Ugly”? Those innovations are the ones which, although born outside healthcare seem to work perfectly within. Often harvested from personal interests, my experience of one such innovation has been with the early successes I’ve had in using Virtual Reality to reduce pain in patients having wound dressings.
The common thread in the success or failure of all three types was the fact that problems need to come before solutions. This is surprisingly difficult to achieve, given the lure of new gadgets and technology.
Much like every NHS employee, locums and sessional doctors are expected to know their job, and get on with it: turning up, seeing the patients, and not upsetting the apple cart.
Yet locums probably have the most to offer when it comes to innovation. Who else sees the breadth of the NHS, working in practices large and small, in- and out-of-hours, and in some of the most challenging circumstances?
They have a unique perspective of not only the problems of their particular clinical existence, but also the issues that those working in one place might overlook. They see solutions in one place that might work somewhere else. Locums are vectors of innovative practice. They may have already developed solutions, innovations, and wanted to share them, but not know how.
The NHS needs to recognise the fantastic resource it has in the sessional workforce and provide help and opportunity for them develop their ideas further. I’ve seen evidence of change in the mindset of the leadership of the NHS, especially in the work of our National Clinical Lead for Innovation, Professor Tony Young, who heads the Clinical Entrepreneur Programme. You can also look to groups such as Doctorpreneurs.
Aren’t we also masters of self-organisation? Why don’t we upgrade our own networks to be more supportive of innovation and entrepreneurship? Perhaps that idea you have, that innovation you’re working on, could be turned into something larger with a little help or guidance?
Back in April I reported on my first RSM Medical Innovations event, which left me energised and considering a membership. In a similar but less impressive fashion to Victor Kiam, I also invested in the company, and so when I attended the 13th Innovation event, I was doing so as a fully paid up fellow of the society.
Not that this was a requirement of attending. Tickets were available for free, although it was understandably over-subscribed. One of the most refreshing features of the RSM innovation event is the diversity of the audience. We had students from a local secondary school, entrepreneurs, scientists, doctors, patients and the ever present wise heads of academia and retired clinicians.
Calmly and capably hosted by President of the RSM, Mr Babulal Sethia, the day was broken into 4 sections, and covered a wide range of medical innovations with speakers from across the world. Some focused on the problems of the developing world which took them ahead of their western peers and colleagues. Others looked to the non-medical disciplines to take a new angle on clinical challenges. There was even disruption of the standard research model, bearing fruit in areas such as regenerative medicine.
We started at the end, with an engrossing presentation from Dallas Pounds, Chief Executive of Royal Trinity Hospice ( www.royaltrinityhospice.london,@trinityhospice ). Currently undergoing a remarkable transformation of it’s own, the ground-breaking team are working hard to take information, support and advice about death and dying ‘on to the high street’, and are blurring the boundaries to allow people in to see their work first hand. We were given a preview of “OddsAndEnds” – a platform which allows people to explore and understand death and dying themselves, which launches in 2017
I’ve spoken about Mr Shafi Ahmed before, reporting on his ground-breaking live broadcast of an operation earlier this year (#VRinOR). He continues to blaze a trail in Virtual Reality education, and today he spoke passionately about the challenges facing the estimated 5 billion people across the globe that lack access to safe surgery. By delivering immersive high quality surgical training using Medical Realities ‘The Virtual Surgeon’ platform, it’s now possible to livestream operations to anywhere with a network connection. Thanks to Facebook and Google, that’s anywhere on the globe. Give it a few years, and Elon Musk will be delivering this to Mars.
It’s #medinnov day and I’ve struck gold already! Doyenne of surgical #VR @ShafiAhmed5 in the house! @roysocmed #innovation #digitalhealth #theta360 – Spherical Image – RICOH THETA
With NooraHealth (@noorahealth), the needs of the developing world also helped drive innovation. CEO Edith Elliott and MD candidate Shahed Alam, students arising from the design school methodology of Stanford, visited India and made brilliant use of the abundant resource of family to put in place an education and training programme that turned family into competent carers, with subsequent significant improvement in post-discharge outcomes. What’s really telling here is that this process would work wonders in the NHS and perhaps other ‘developed’ healthcare systems, as well as helping to improve quality and meet rising demand.
The work of Professor Helen Lee in developing a robust, simple, ‘nespresso’ style point of care test for bloodbourne viruses that would work in the heat and noise of Ghana was next. Innovation faces challenges from all sides, and the simple reality of operation and supply chain in Africa can get in the way of even the most elegant of solutions. By concentrating on the challenges faced by front-line workers, ‘Diagnostics for the Real World‘ have produced an award winning solution that can transform the diagnosis of these illnesses.
Alongside the growing problem of HIV, Iron Deficiency Anaemia affects 3.5 BILLION people across the globe. Yes, that’s a “B”. The associated health and developmental issues can significantly shorten lifespan and affect quality of life and economic output. Yet solving this problem, by providing suitable iron supplementation, has challenged even the brightest minds. Enter Dr Gavin Armstrong with the cute ‘Lucky Iron Fish’ (@luckyironfish). By providing a small iron fish which can be boiled for 10 minutes with their food, people can significantly supplement their iron intake without affecting flavour or causing significant side effects.
Once again, the idea and science might be smart, but the allied entrepreneurship, social marketing, cultural understanding and even the ‘buy 1 give 1’ plan have gone a long way to making this venture a success. Gavin was equally honest in sharing the important role of failure in learning and growing. In many ways I was put in mind of the work Lauren Braun and Alma Sana, who were one of my highlights of the previous RSM event I attended. You’ll appreciate why I immediately connected the two on twitter!
Innovation needn’t spring from within healthcare to work – in fact, looking outside traditional silos is a brilliant way of approaching problems in a novel way. For example, 3D printing technology has already found a place in traditional design and manufacture, but is increasingly being used by enterprising clinicians and scientists in surgery, training, and device manufacture. Had you ever thought about using it to produce a model of a diseased prostate to allow for surgical planning and patient education though? Thought not.
Hugo Lynch, founder of MPrint3D, and Mr Richard Hindley, Conslutant Urological Surgeon from the Hampshire Hospitals NHS Trust, have moved from the already-awesome ‘fusion’ of high resolution MRI and ultrasound (which allows for extremely accurate transperineal prostate biopsy) to having the data converted to a solid object that can be handled by surgeon and patient alike. Yes – this means a 3d printed prostate. And yes – in what must be a world-first I got a selfie with it.
What’s immediately apparent is the incredible ability of a physical object to quickly and easily allow comprehension of what is often impenetrable information for both doctor and patient. Whether 3D printing is the best solution, or whether Virtual and Augmented Reality might perform as well, we shall see.
This is a question that is being answered by 3D4Medical (@3d4medical). Their iPad Anatomy series of apps have already revolutionised what is possible with tablet based anatomy teaching, a fact not lost on Apple themselves who invited them to help launch the iPad pro 2 years ago. It’s an amazing, intuitive and interactive piece of software, something I wish I’d had as a medical student back in the 1990’s. Dr Alan Detton & Niall Johnson took us through the latest version of the app, and offered a tantalising glimpse at ‘Project Esper’, their next step into Augmented Reality.
It was great to see Mindmate (www.mindmate-app.com@MindMateApp) making an appearance as well. Developed with the support of the Digital Health & Care Institute of Scotland (@DHIScotland), Patrick Renner took us through a slick presentation highlighting the features of this app, which provides assistance for people living with Dementia. We were joined by co-founder Susanne Mitschke (@susanneMitschke) via the app itself. By working closely with patients, families, and their care providers, the founders have used their experience in business, economics, and social sciences to accelerate the growth and adoption of this platform, which now has 12’000 monthly users.
Whilst the RSM, with its 182 year history, might be built on solid academic and research foundations, but it’s not shy of showcasing radical changes to this model.
iCancer is a crowdfunding campaign that famously raised £2million in just eight months to fund an oncolytc virus into Phase 1/2a trials. Liz Scarff, Alexander Masters, and Dominic Nutt, all personally touched by the effects of Neuroendrocrine tumours, brought together crowdsourced funds to directly revive a quiescent research corner into a rare disease. They then combined with a rich donor utilising ‘the Plutocratic Principle’ – where one wealthy individual can meet the majority of the cost of a trial and not only personally benefit, by entering that trial t hemselves (or allowing a friend/family member to do so) but also allow for many more people to benefit from the work. Strict ethical guidance is brought to bear, but with the generosity of donors forgotten research can be brought back to life, with the potential of developing novel treatments for all to share.
Ever heard of Bioelectronics? No, neither had I, until today. Dr Kris Famm, President of Galvani Bioelectronics, and Dr Nishan Ramnarain, Consultant in Pharmaceutical Medicine and Experimental Medicine Director at GlaxoSmithKline (@gsk), took us through some background on the use of precision modulation of nerve signals to control organ response and, thereby, whole system disease. For example, manipulation of the sympathetic nervous system at the carotid body can, in turn, help regulate blood sugar and blood pressure. Control of the sympathetic nervous system has long been known to play a crucial part in many illnesses, and treatment. When I was a junior doctor, I recall my surgical registrar opting for a highly selective vagotomy for his stomach ulcer over taking omeprazole. A whole class of medication is used to achieve the same effects. Having a new method of
Finally, we had two extremes to highlight the value of digital research tools:
At one end – Osman Kibar from Samumed (@Samumed_LLC). A serial entreprenuer and innovator, he presented some of the first findings of research into the existing corpus of knowledge on the Wnt signalling pathway. Through careful search methods, his company claims to have found a unique group of compounds that can modulate this biochemical pathway. This, in turn, has applications in regenerative medicine, degenerative disease and cancer. Showing evidence of paralysed mice walking again is strong stuff, and elicited an excited and slightly sceptical response from the audience.
At the other end, we had Renuka Chintapalli. Still at secondary school, she published her first paper aged 15, looking at the anti-cancer properties of common garlic. As if this wasn’t humbling enough, she has gone on to identify a novel bio-marker for oesophageal cancer by searching existing databases.
It’s always difficult to pick a highlight at an event like this, but my personal favorite had to be the presentation by Dr Liberty Foreman and Dr Katie Oliver, co-founders of Beamline Diagnostics (@beamlined). The technology is impressive in its own right, using computational statistics to analyse data from infrared spectroscopy to detect the ‘chemical signature’ of early cancer changes. This has the scope to massively reduce the number of pathological samples that need formal scrutiny by allowing an accurate method of rapidly screening biopsy samples for cancerous changes. They’ve turned this into a product that can be operated at point-of-care too.
We have innovation in software, resurrection of a little used hardware modality, and a rapid practical impact on patient care in one. All of this would generally be enough to mark them out from the crowd, but what pushed them over the top was the refreshing honesty from the founders in how they formed their company – they just did it. Now faced with the tidal wave of new challenges, they push on regardless and deservedly look to make a success of their brave decision.
It’s the #JFDI* principle that is my personal mantra, and it’s a common thread in the innovations that tend to make the biggest impact. Is this because it indicates a personal characteristic in the inventor or founder of these projects? Does it mark the necessary bravery and energy required to break through the traditional barriers and inertia to change? Or is it just the troublemaker tendency in everyone that embarks on their quest to change things for the better? Whatever the answer, it makes events such as these endless entertaining, optimistic, and inspiring.
Finally, it was left to Dr Cristina de Juan (@cristina_djsj) from InnovateMedTec.com to wrap up, with a call for collaboration and connection across the globe to accelerate innovation. You can all take part, online, or in person, by attending the next event. Mark Saturday 22nd April, 2017 in your diary – I’ll see you there.
I am a fellow of the Royal Society of Medicine, mainly because I was so impressed by the venue and quality of the meetings when I came to the last event. I cover the membeship costs personally. The event was free to attend for all, and I paid all travel and food expenses, apart from the coffee served at the intervals!
Of course, I also wore my #PinkSocks – see previous post about the provenance of these fine items.
“The one thing that the NHS cannot afford to do is to remain a largely non-digital system – it is time to get on with IT”
The Health & Care Innovation Expo 2016 is now entering its third year of showcasing the very best of innovation in the NHS. Hosted by NHS England, and held in the steampunk Victorian grandeur of the Manchester Central Conference Centre, I took part in 2 packed days of talks, workshops, demonstrations and general flights of wild innovative fancy with a wide range of attendees. The importance of the event was underlined by the prestige and range of speakers, from Professor Sir Bruce Keogh opening the event and chairing numerous panels, to Professor Bob Wachter MD talking about his review into digital usage in the NHS. We even had a hirsute Simon Stevens delivering a keynote and a full hour of Jeremy Hunt’s time, where he launched the next phase of the Digital NHS roadmap.
In truth there was a little too much to wrap my head around. The show floor was packed with exhibitors large and small, and an interesting range of stands exploring the ‘feature zones’ of New Care Models, NHS Right Care, Digital Health, and Personalised Medicine. Given the long queues for some of the talks, not to mention the numerous pop-up events and side meets, the one innovation we were all in need of was more time.
The announcements were, as tradition dictates, presented in the morning papers and we heard about the coming year’s targets on the journey to a digitised NHS in 2020. Primary care is in a good place here – in fact, Jeremy Hunt commended GPs for ignoring the government advice and ploughing their own furrow when faced with Connecting for Health. Without this, he said, we would be significantly further behind. Interesting advice on avoiding governmental advice there.
The news broke down as follows:
Patients will be able to book appointments, order medications, and download records, US ‘Blue Button’ style, on a revamped www.nhs.uk to be launched at Expo 2017.
Anyone will be able to access detailed stats on performance in key areas such as dementia, diabetes, and learning disabilities
There will be online access to 111, which can lead to direct appointment, signposting, or callbacks.
By March 2017 there will be a directory of approved apps from March 2017, with subsequent support for wearables
The creation of a second round of ‘national’ excellence centres, with more detail to follow.
The creation of an NHS Digital Academy to teach Informatics skills to NHS staff and create the next generation of Clinical Chief Information Officers and Digital Health Leaders.
Response to these announcements was mixed, both at the expo and in the press. On the one hand, when you combine this with the Tech Tariff (on which there was little news), it’s yet more evidence that the NHS is making good on the promise to step into the 21st century. Entrepreneurs and startups might complain that it doesn’t go far enough, and that the route to approval is still too long-winded and narrow. There was also the usual chorus of disapproval for any non-evidenced interventions in the NHS, and possible willful misinterpretation of what was being offered as simply a way of fobbing patients off with an app instead of a doctor. Those of us with a role in innovation have a responsibility to ensure that expectations are managed appropriately: Digital Health is NOT a panacea, but is instead another weapon in our fight against illness and social problems. We also need to ensure that evidence is generated and shared whilst trying to balance the pace of technological change against that of traditional research.
My presence at the expo was as innovations lead for my CCG (Eastbourne Hailsham & Seaford, and Hastings & Rother), and so it was exciting to be able to share the stage with Professor Sir Bruce Keogh, Dr Mahiben Maruthappu(@M_Maruthappu), Mr Ashish Pradhan & Maria Slater. Our panel, ‘Achieving Innovation at scale in the NHS’ hoped to inform the debate about how we can turn small scale innovation (which the NHS is brilliant at) into widely adopted, large scale change (not so good). The vehicle of the NHS Innovation Accelerator, which I have spoken of previously, is beginning to deliver, and I was one of three speakers talking about current NIA products.
Mr Pradhan is a Consultant Subspecialist Uro-Gynaecologist at University Hospitals NHS Foundation Trust, Cambridge. Episcissors – 60 are fixed angle episiotomy scissors, which are used to assist with incisions for difficult births that avoid the complication of damage to the anal sphincter and subsequent problems with continence. Undeniably, a brilliant idea, but the point was made that a business case was hard because this cheap intervention actually reduces hospital income down the line! The NHS is littered with such perverse incentives not to innovate, all of which need addressing.
When it came to me, my story was simple – having an excellent product is NOT enough. AliveCor is, undoubtedly, a great product which works very well at identifying asymptomatic Atrial Fibrillation (AF) as well as other rhythm disturbances, but from pilot work and a wider scale roll out in my CCGs, uptake has been slow. This reinforces the need to carefully consider how to manage change when introducing innovation, as well as considering the practical aspects and the need for education and support.
Even so, with lower uptake than expected, we detected 61 new cases of AF which, if treated appropriately, would have significantly reduced the risk of stroke in the target population. In effect, we may have avoided up to 3 strokes per year even in this small group. Numbers like that surely warrant support!
It was also great to be able to celebrate East Sussex Better Together and our progress towards a single Accountable Care Organisation. By working together with acute trusts, community trusts, and social care, we are moving towards a world where the “perverse incentives” mentioned in Episcissors story are a thing of the past. Costs are no longer saved in someone else’s budget
You could have spread the event over a week and still not had the opportunity to catch the majority of the content. I attended talks about the GP Forward View, Urgent & Emergency Care Innovation, and even learning from high performance and marginal gains theory in a talk called “Black Box Thinking” from Matthew Syed(@matthewsyed). Innovation is more than just technology, and sometimes the change in mental perspective towards one of continual marginal improvement is the most difficult of all.
My personal favorite technology, Virtual Reality (VR), was a little thin on the ground. We had VR from treating Obsessive Compulsive Disorder from a company called Mindwave Ventures(@mindwave_). They are using VR to create what must be the most disgusting bathroom since Trainspotting to help patients gradually address their fears of contamination. Augmented Reality was showcased from AMA(@AMAapplications), whose Xpert Eye platform will soon be used in my area to allow doctors to remotely visit care home patients. I also have to confess that my day (and probably whole week) was made when I discovered that the MSD team had brought Microsoft Hololens(@hololens). I can only apologise to everyone that had to experience my excited swearing as I strolled around an alternate reality populated with tigers, sharks, and a ghostly vitruvian man with a glowing nervous system.
Having spoken at TEDxNHS(@TEDxNHS), it was lovely to meet Dr Jon Holley (@jonnyholley), Dr Manpreet Bains(@manpreetbains_1) and the team again at their stand. The video footage from the event is in the edit and I’m assured will be available soon. It even led to one of the more surreal moments of the event where I got pulled out of a talk on Urgent Care to demonstrate VR to Ruby Wax ahead of her talk on Mindfulness and Mental Health.
I’ve made no secret of my love for the US way of approaching innovation, and how they celebrate the possibilities whilst including patients, especially in the Stanford Medicine X conferences. Thanks to speakers like Roy Lilley(@RoyLilley) who talked energetically about the importance of innovation from the front line, challenged pretty much everyone he spoke to to think differently, and who then danced off to ‘Always look on the bright side of life’ after his talk, I think I can now see the British version of this optimism, and the contagion is spreading.
Innovation now has fewer barriers than ever in the NHS, although those that remain are substantial. It’s over to us to make sure that next year for Expo 2017 we have some real success stories to share, alongside the courage to share and learn from our failures.
DECLARATION OF INTERESTS
I attended in my role of CCG Innovation Lead & Governing Body Member of EHS/HR CCG. As a speaker, all travel, accommodation fees met by the event organisers. I received no speaker fee.
Oh, I also wore #PinkSocks throughout, in the spirit of #JFDI and #GSD. These were a gift from Eugene Borukhovic (@healtheugene)
You may characterise the NHS as many things, but I’d wager that being bold and having the ability to surprise is not one of them. Yet here we are, with another unexpected development in the world of Digital Health that is further evidence that the NHS is finally going to walk the walk, and not just talk endlessly about innovation.
I’m referring to last week’s announcement of an Innovation & Technology Tariff. Up until now, MedTech innovations had a rather convoluted and indistinct path to the patient’s bedside, with great variability between regions and no single, clear method of getting there. Even where technology has been demonstrated to benefit patients, scaling it has been frustratingly tough. At times it appeared that the NHS was actually acting against innovation, with perverse financial incentives not to change.
The mysterious new tariff became one of the talking points at the Digital Health panel at the 8th annual Future of Wireless festival. I was invited to talk about my ‘coal face’ experience of innovation in primary care, alongside Francis White (@francisww – AliveCor), Shamus Husheer (@susheer – Heartfelt Technologies), and Steve Feast (@drstevefeast – MD Eastern Academic Health & Science Network). Chaired by Nick Hunn (@nickhunn – WiFore), it was an honest and fascinating view of developing and implementing MedTech innovation in the NHS and across the world. Turns out the NHS is not quite the technological backwater we all thought it was, with markets across the planet providing their own unique challenges.
In my talk I described my own journey of discovery, from finding out about Alivecor at an innovation event in Scotland hosted by the Digital Health & Care Institute (@dhiscotland), through to testing it on myself and my patients, to finding a local specialist champion and working with him and my CCG to find the funds, and finally distributing the devices to the practices of Eastbourne Hailsham & Seaford, and Hastings & Rother. And then….nothing. Uptake of the use of the device has been slow, even in the face of good local evidence of benefit. Why is that?
It seems that just providing the device and having enthusiastic supporters is not quite enough. Alivecor is very much one of the stars of the current crop of approved innovations, but to embed it into routine practice requires many more steps – the development of a clear protocol for use by clinicians, implementing processes by which the data are reviewed and actioned, and the finding additional hardware and support resource. I’ve found all of this out at the coal face, and Alivecor have been great in working with me and sharing the knowledge to their user base. Partnering with front-line users is key.
Will the new tariff fix this? In short, it’s too early to tell, and while I’m enormously encouraged by the development, it’s clear from my experience thus far that just paying for progress is not enough. The old issues of change management are still there, and speaking from a primary care perspective, the enormous workload burden means that any innovations have to be implemented with the minimum extra investment of time and effort, whilst at the same time improving care quality AND reducing workload. No small feat.
Yet I am optimistic. I’ve seen the incredible passion for invention and delivering world-class healthcare in the NHS from patients, clinical & non-clinical staff, management, and the host of SMEs and startups basing themselves in the UK. We have the finest academics on the planet. In my own area, the East Sussex Better Together programme is bringing health and social care together to radically transform our ability to work jointly on the problems faced by local people. The new tariff might open up new possibilities here too.
There is a lot of talk about ‘Unicorn’ organisations in business – those companies that achieve a magical ‘ $1 Billion’ valuation. I’d like to reclaim the term and apply it to my NHS. It is a rare and mythical beast, with magic where it counts: a comprehensive healthcare system, provided free at the point of delivery based on need, not ability to pay. With some of the last barriers to a 21st century upgrade being removed, there’s no limit to what we can do.
You can read more at about the Innovation & Technology Tariff at